Aug 24 (Reuters) - A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Biosciences and the University of Washington after finding that the company infringed patents ...
Medical Device Network on MSN
Guardant ordered to pay $245M in DNA sequencing patent dispute
Guardant plans to appeal the ruling, taking particular issue with a 6% ongoing royalties stipulate outlined in the court’s ...
Researchers have developed a simple, low-cost blood test that identifies a distinctive chemical signature of lung cancer cells, distinguishing patients from healthy individuals with high accuracy ...
This image compares three DNA sequencing technologies: Sanger sequencing, Massively Parallel DNA sequencing, and Nanopore DNA sequencing. Sanger sequencing (left) sequences 500-700 bases per reaction ...
In recent years, technologies that allow scientists to study a person's DNA at single-molecule resolution have vastly expanded our knowledge of the human genome, the microbiome, and the genetic basis ...
A complete guide to next-generation sequencing: the chemistry behind major platforms, how libraries are built, data analyzed, ...
Precise activation of tens of thousands of genes is critical for healthy development and growth. Specialized segments of our DNA are responsible for carefully orchestrating genetic sequences that ...
Reimagined undergrad class teaches students entire DNA sequencing process using cutting-edge devices
Students take samples of water and the microscopic creatures within at the Alviso Marina County Park. (Image by Erika Cardema) At the Alviso Marina County Park, reddish-brown water laps at the edge of ...
Forensic DNA analysis has come a long way, from conventional blood-grouping methods to STR profiling and, more recently, ...
Die SeqLL-Aktie gehört zu einem kleinen Spezialanbieter für DNA-Sequenzierung im Forschungssegment. Der Fokus auf Nischenanwendungen und Partnerschaften prägt das Profil des US-Unternehmens. SeqLL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results